GE HealthCare announced essentially flat organic growth in the first quarter of this year compared to Q1 last year, and a 1% decrease in revenue year-over-year, from $4.7 billion in 2023 to $4.65 billion in 2024, causing its stock price to plummet 14.3%.
The company reported a net income of $374 million in the first quarter, compared with $372 million in the prior-year period, and adjusted...
GE HealthCare has partnered with radiation therapy company Elekta to develop new software to improve clinicians experience and enable greater precision treatment.
Elekta will use GE HealthCare’s MIM Software imaging management platform, which GE HealthCare acquired earlier this month. MIM’s auto contouring and treatment management platform will allow Elekta to develop radiation oncology...
Microsoft, GE HealthCare, and LG Electronics have recently partnered with a shared goal of supporting smart hospital constructions in South Korea.
The trio have signed a memorandum of understanding to collaborate and contribute their respective expertise in medical equipment and medtech solutions, smart hospital operation solutions, and cloud and platforms.
In particular, Microsoft Korea will...
Chicago-based GE HealthCare announced it closed its acquisition of AI and imaging solutions company MIM Software, expanding its digital imaging offerings.
Cleveland-based MIM Software provides remote software solutions for oncology, nuclear medicine, cardiac imaging and neuroimaging.
The company touts its products as reducing time spent on manual tasks, allowing clinicians to focus on providing...
GE HealthCare announced that its Brazil-based partner Ionic Health received FDA 510(k) clearance for its nCommand Lite, which provides diagnostic imaging centers with real-time scanning, remote guidance and operational support, and the ability to view/review images remotely.
Ionic’s software interacts with equipment like a local technician, enabling remote operation of MRI, CT and PET scans with...
GE HealthCare received FDA 510(k) clearance for its Novii+ maternal and fetal monitoring solution, which will become available to U.S. customers later in the year.
The device, consisting of a wearable and wireless sensor, enables noninvasive measurement and display of fetal heart rate, maternal heart rate and uterine activity for pregnant patients at or beyond 34 weeks.
With the expanded...
GE HealthCare is leveraging AI and data integration technologies to help tackle the rapidly increasing volume of patient data and working to optimize the application of these two tech tools in patient care in announcing 40 new innovations at RSNA23.
The company's central strategy is to integrate AI into its precision care framework, encompassing smart devices, targeted therapies, disease-...
GE HealthCare announced a collaboration with Grand Rapids-based cancer treatment center BAMF Health to advance the adoption of theranostics in the U.S.
Theranostics is an emerging technology and a form of precision medicine that fuses imaging technology with therapeutic agents to pinpoint and target cancer cells for destruction.
BAMF Health offers molecular imaging for various types of cancer as...
GE HealthCare reported its third-quarter earnings today, noting revenue of $4.8 billion, a 5% year-over-year revenue growth and 6% organic revenue growth, seeing its stock price rise.
The company, which officially spun out of GE earlier this year, reported $375 million in net income compared to $487 million compared to the prior-year period, with a net income margin of 7.8% versus 10.6%,...
GE HealthCare announced it signed a $44 million contract with the Biomedical Advanced Research and Development Authority (BARDA) to develop AI-enabled point-of-care ultrasound technology to help clinicians diagnose and treat lung pathologies and traumatic injuries to the head, chest and abdomen.
The medtech company will build off its existing ultrasound technology to develop an AI-powered...
